More than two million Americans struggle with atrial fibrillation. Atrial fibrillation, or AFib, is one of the most common heart rhythm disorders. But treatment only works about half the time. Now, ...

Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...

MENLO PARK, Calif., April 30, 2019 /PRNewswire/ -- Ablacon, Inc. (www.ablacon.com), a Wheat Ridge, CO-based company developing an advanced mapping system to guide the treatment of atrial fibrillation ...

Using Rhythm AI Ltd.'s stochastic trajectory analysis of ranked signals (STAR) mapping system with pulmonary vein isolation terminated and eliminated recurrence of persistent atrial fibrillation (AF) ...

Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology. MENLO PARK, Calif., Dec. 7, 2023 ...

Please provide your email address to receive an email when new articles are posted on . Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial ...

Dr Azlan explains how the system maps the heart tissue in 3D, with different colours indicating the different conditions of the tissue. — IJN Atrial fibrillation (AFib) is not only the most common ...

Please provide your email address to receive an email when new articles are posted on . In a small study, a noncontact mapping algorithm was faster and better identified complex atrial arrhythmias ...

KUALA LUMPUR, Feb 25 (Bernama) -- Institut Jantung Negara (IJN) has achieved a significant medical milestone by becoming the first hospital in Asia to clinically utilise the Affera Prism-2 Mapping and ...

MIAMI. (Ivanhoe Newswire) – Atrial fibrillation, or AFib, is one of the most common heart rhythm disorders. But treatment only works about half the time. Now, that may be about to change, thanks to a ...